Abstract Background Microaxial flow pumps (mAFP) are a well-established treatment modality for patients in cardiogenic shock, significantly improving hemodynamics and end-organ-function. In complex heart failure patients currently ineligible for advanced heart failure therapies, such as durable left ventricular assist device (dLVAD) implantation or heart transplantation (HTx), mAFP can serve as a preconditioning tool in a bridge-to-candidacy strategy. Case summary A 61-year-old male patient with known dilatative cardiomyopathy and multiple comorbidities presented in cardiogenic shock, accompanied by end-organ dysfunction, fluid overload, and the need for moderate catecholaminergic support. Bilateral lower limb stasis dermatitis with infected ulcers excluded advanced heart failure surgery. Initial management included high-dose diuretics, paracenteses and pleural drainage. To further improve microcirculation and optimize conditions for ulcer treatment, ongoing hemodynamic support was escalated through the implantation of a full-support transaxillary mAFP. Comprehensive wound care was initiated with successful split-thickness skin grafting during ongoing mAFP support. Given favorable wound healing, the patient underwent uncomplicated dLVAD implantation. Early postoperative right heart failure necessitated continued inotropic support. Following high-urgency HTx listing the patient was successfully transplanted eight months later. Conclusion Medium-term full support mAFP provided robust circulatory output, enabling effective decongestion and wound healing in a bridge-to-candidacy approach.
Stegmann et al. (Tue,) studied this question.